Central Plaza
49th Floor Rooms 4902-03 18 Harbour Road
Wan Chai
Hong Kong
852 2688 0869
https://www.ssygroup.com.hk
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 5,640
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Jiguang Qu | Chairman & CEO | 6.69M | N/D | 1955 |
Mr. Hing Yeung Chow | CFO, Company Secretary & Executive Director | 1.1M | N/D | 1979 |
Mr. Xuejun Su | Executive Director | 1.72M | N/D | 1969 |
Mr. Guo Meng | Deputy GM & Executive Director | 1.22M | N/D | 1975 |
SSY Group Limited, an investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People's Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials. In addition, the company is involved in the research, development, and consulting of pharmaceutical technology; provision of logistics services for pharmaceutical products; food, beverages, and catering businesses; and production and sale of methylamine. It sells its products under the Shimen brand name. The company was formerly known as Lijun International Pharmaceutical (Holding) Co., Ltd. and changed its name to SSY Group Limited in May 2015. The company was founded in 1999 and is headquartered in Wan Chai, Hong Kong.
La calificación ISS Governance QuickScore de SSY Group Limited a partir del 1 de mayo de 2024 es 9. Las puntuaciones principales son Auditoría: 6; Junta: 7; Derechos del accionista: 7; Compensación: 8.